(GN) GN Store Nord - Ratings and Ratios
Exchange: CO • Country: Denmark • Currency: DKK • Type: Common Stock • ISIN: DK0010272632
GN: Headsets, Hearing Instruments, Video Cameras, Speakerphones
GN Store Nord A/S is a leader in the development of innovative audio and hearing solutions, operating through two distinct segments: GN Hearing and GN Audio. The GN Hearing division specializes in advanced hearing instruments and related products, addressing a growing demand for auditory health solutions. GN Audio, on the other hand, caters to both professional and consumer markets, offering a range of headsets, video conferencing equipment, and gaming peripherals under well-known brands like Jabra, SteelSeries, and BlueParrott. This dual focus positions the company at the intersection of healthcare and consumer electronics, allowing it to leverage technological advancements across both fields.
Founded in 1869 and headquartered in Ballerup, Denmark, GN Store Nord has built a legacy of innovation and quality. The companys extensive brand portfolio includes ReSound, Beltone, and Interton, each contributing to its strong market presence. GN Store Nords global reach extends across Europe, North America, and international markets, with a significant emphasis on emerging regions where demand for hearing and audio solutions is rapidly increasing. This strategic diversification not only enhances revenue resilience but also underscores the companys commitment to global accessibility.
From a financial standpoint, GN Store Nord A/S presents an intriguing profile for investors. With a market capitalization of 21,696.34M DKK, the company demonstrates substantial scale and stability. The current P/E ratio of 33.11 reflects investor confidence in its growth prospects, while the forward P/E of 12.44 suggests expectations of continued profitability. A P/B ratio of 2.15 indicates that investors value the companys assets, likely due to its strong brand equity and R&D investments. The P/S ratio of 1.20 highlights efficient revenue generation relative to its market value. These metrics, combined with the companys R&D focus and market leadership, make GN Store Nord a compelling consideration for those seeking exposure to both healthcare and technology sectors.
Additional Sources for GN Stock
GN Stock Overview
Market Cap in USD | 2,489m |
Sector | Healthcare |
Industry | Medical Devices |
GiC Sub-Industry | Health Care Equipment |
IPO / Inception |
GN Stock Ratings
Growth 5y | -70.7% |
Fundamental | 19.1% |
Dividend | 20.1% |
Rel. Strength Industry | -25.1 |
Analysts | - |
Fair Price Momentum | 95.39 DKK |
Fair Price DCF | 186.62 DKK |
GN Dividends
Dividend Yield 12m | 0.00% |
Yield on Cost 5y | % |
Annual Growth 5y | -100.00% |
Payout Consistency | 67.0% |
GN Growth Ratios
Growth Correlation 3m | -16.4% |
Growth Correlation 12m | -83.7% |
Growth Correlation 5y | -81.8% |
CAGR 5y | -14.05% |
CAGR/Max DD 5y | -0.17 |
Sharpe Ratio 12m | -1.79 |
Alpha | -31.71 |
Beta | 0.69 |
Volatility | 48.29% |
Current Volume | 530k |
Average Volume 20d | 616.5k |
As of March 15, 2025, the stock is trading at DKK 117.65 with a total of 529,981 shares traded.
Over the past week, the price has changed by -5.88%, over one month by -17.76%, over three months by -9.12% and over the past year by -24.39%.
Neither. Based on ValueRay Fundamental Analyses, GN Store Nord is currently (March 2025) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of 19.07 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of GN as of March 2025 is 95.39. This means that GN is currently overvalued and has a potential downside of -18.92%.
GN Store Nord has no consensus analysts rating.
According to ValueRays Forecast Model, GN GN Store Nord will be worth about 103 in March 2026. The stock is currently trading at 117.65. This means that the stock has a potential downside of -12.44%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 186.5 | 58.5% |
Analysts Target Price | - | - |
ValueRay Target Price | 103 | -12.4% |